Dr. Versha Banerji obtained her MD and residency training in Internal Medicine and Hematology at the University of Manitoba. She then completed a post-doctoral fellowship in translational research at the Harvard Cancer Centre/ Dana-Farber Cancer Institute and Broad Institute of MIT. She is a Senior Scientist at the CancerCare Manitoba Research Institute, Associate Professor at the University of Manitoba, and a Clinician-Scientist at CancerCare Manitoba. She co-leads the CLL clinic and is involved in several clinical trials and population-based treatment studies.

As co-chair of the CLL Research Program, she manages a multi-disciplinary research team in clinical, fundamental and translational research. Her own laboratory is evaluating novel therapeutics and the impact on mitochondrial function and metabolism.